Price · as of 2025
$13.54
Market cap 2.84B
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $1,299.14 | +9,495% |
| P/E | -3439.80 | |
| P/B | 18.76 | |
| P/S | 0.85 | |
| EV/EBITDA | 68.17 | |
| PEG | — | |
| P/TBV | 23.58 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $9.33 | $50.84 | |||
| 2022 | $6.08 | $14.27 | |||
| 2023 | $5.39 | $13.15 | |||
| 2024 | $14.89 | $18.47 | |||
| 2025 | $16.99 | $19.29 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
- CEO
- John E. Kao
- Employees
- 1.85K
- Beta
- 1.05
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ALHC | Alignment Healthcare, Inc… | $13.54 | 2.84B | $19.29 | +42% | -3439.80 | 18.76 | 0.85 | 68.17 | — | 23.58 | 12.37% | 0.37% | -0.02% | -0.70% | -21.56% | -0.11% | 1.84 | 0.93 | 1.71 | 1.54 | -5.43 | -99.45% | 46.06% | -1801.96% | 3.36% | 0.25 | -165.36% | 0.00% | 0.00% | 4.24% | 209.43 | 27.31 | 0.78 | 5.15 |
| APGE | Apogee Therapeutics, Inc. | $134.84 | 8.34B | — | — | -17.06 | 4.83 | — | -14.33 | -61.18 | 4.83 | 0.00% | 0.00% | 0.00% | -31.57% | -146.27% | -30.26% | 0.01 | — | 26.57 | 26.38 | 0.48 | 27.88% | — | 34.97% | -5.33% | -8.15 | -119.12% | 0.00% | 0.00% | 0.00% | -12.75 | -15.66 | — | 77.81 |
| DYN | Dyne Therapeutics, Inc. | $26.25 | 4.9B | — | — | -5.16 | 2.37 | — | -2.77 | -173.83 | 2.37 | 0.00% | 0.00% | 0.00% | -55.71% | 878.42% | -47.52% | 0.02 | -75.61 | 22.25 | 21.94 | 1.99 | 2.97% | — | 37.45% | -17.60% | -7.96 | 760.11% | 0.00% | 0.00% | 20.06% | -2.59 | -2.99 | — | 4.57 |
| GRAL | GRAIL Inc. | $69.48 | 2.98B | $13.73 | -80% | -3.88 | 0.61 | 10.75 | -2.05 | — | 2.18 | -42.52% | -362.95% | -277.47% | -16.07% | -22.80% | -13.83% | 0.04 | — | 11.97 | 11.58 | 0.40 | -82.51% | 17.18% | -48.50% | -18.95% | -3.75 | -16.76% | 0.00% | 0.00% | 0.36% | -1.45 | -2.59 | 5.27 | -2.33 |
| ICUI | ICU Medical, Inc. | $184.56 | 4.61B | $73.31 | -60% | 4236.26 | 1.46 | 1.39 | 12.82 | — | -326.83 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -100.61% | -6.38% | -26.36% | 2.96% | 0.36 | 2.82% | 0.00% | 0.00% | 8.31% | 39.13 | 45.59 | 1.88 | 2.04 |
| MIRM | Mirum Pharmaceuticals, In… | $100.65 | 6.14B | $44.25 | -56% | -194.79 | 14.46 | 8.73 | 260.79 | — | 84.64 | 80.71% | -4.25% | -4.48% | -8.65% | -8.61% | -3.09% | 1.02 | -1.54 | 2.67 | 2.46 | 1.32 | -74.59% | 54.74% | 488.01% | 1.21% | 0.27 | 21.36% | 0.00% | 0.00% | 1.59% | -202.71 | 81.77 | 8.61 | 5.08 |
| NVST | Envista Holdings Corp | $28.15 | 4.58B | $33.17 | +18% | 87.97 | 1.33 | 1.52 | 13.71 | — | 34.20 | 55.02% | 8.30% | 1.73% | 1.56% | 2.61% | 0.85% | 0.51 | 6.17 | 2.38 | 1.93 | 1.17 | -104.31% | 8.32% | -23.89% | 5.57% | 0.32 | 6.67% | 0.00% | 0.00% | 6.27% | 20.03 | 19.62 | 1.66 | 1.71 |
| OSCR | Oscar Health, Inc. | $27.90 | 7.23B | $59.34 | +113% | -7.84 | 3.55 | 0.30 | 0.23 | — | 3.55 | 14.38% | -3.39% | -3.79% | -44.49% | 23.17% | -7.93% | 0.44 | -22.52 | 0.95 | 0.91 | 5.99 | -1865.94% | 27.50% | 11.38% | 30.49% | 0.23 | -61.87% | 0.00% | 0.00% | 32.16% | 0.22 | -0.08 | -0.01 | 1.26 |
| PRVA | Privia Health Group, Inc. | $22.45 | 2.83B | $39.60 | +76% | 115.57 | 3.59 | 1.25 | 40.46 | 181.61 | 8.50 | 9.87% | 1.61% | 1.08% | 3.34% | 11.12% | 1.83% | 0.01 | — | 1.60 | 1.55 | -8.73 | 63.64% | 22.26% | 55.57% | 6.12% | 0.29 | 77.85% | 0.00% | 0.00% | 0.00% | 63.64 | 13.43 | 1.03 | 4.52 |
| RARE | Ultragenyx Pharmaceutical… | $25.91 | 2.55B | $9.58 | -63% | -3.66 | -26.30 | 3.13 | -5.67 | — | -7.01 | 83.80% | -79.49% | -85.44% | -656.03% | -567.31% | -37.89% | -15.95 | -8.63 | 2.48 | 2.22 | -1.78 | -7.31% | 20.13% | 11.93% | -22.43% | -1.21 | -500.50% | 0.00% | 0.00% | 0.00% | -5.02 | -5.69 | 3.99 | -3.62 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1,299.14 ÷ $13.54) − 1 = +9,494.83% (IC, example).